Your browser doesn't support javascript.
loading
Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene.
Clayton, Joshua S; Vo, Christina; Crane, Jordan; Scriba, Carolin K; Saker, Safaa; Larmonier, Thierry; Malfatti, Edoardo; Romero, Norma B; Ravenscroft, Gianina; Laing, Nigel G; Taylor, Rhonda L.
Affiliation
  • Clayton JS; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia. Electronic address: joshua.clayton@perkins.org.au.
  • Vo C; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
  • Crane J; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
  • Scriba CK; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia; Neurogenetics Laboratory, Department of Diagnostic Genomics, PP Block, QEII Medical Centre, Nedlands,
  • Saker S; Genethon, DNA and Cell Bank, 91000 Evry, France.
  • Larmonier T; Genethon, DNA and Cell Bank, 91000 Evry, France.
  • Malfatti E; APHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor Hospital, France; Université Paris Est, U955, INSERM, IMRB, F-94010 Créteil, France.
  • Romero NB; Sorbonne Université, Myology Institute, Neuromuscular Morphology Unit, Center for Research in Myology, GH Pitié-Salpêtrière, Paris, France; Centre de Référence de Pathologie Neuromusculaire Paris-Est, GHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Ravenscroft G; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
  • Laing NG; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
  • Taylor RL; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
Stem Cell Res ; 77: 103411, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38582058
ABSTRACT
RYR1 variants are a common cause of congenital myopathies, including multi-minicore disease (MmD) and central core disease (CCD). Here, we generated iPSC lines from two CCD patients with dominant RYR1 missense variants that affect the transmembrane (pore) and SPRY3 protein domains (p.His4813Tyr and p.Asn1346Lys, respectively). Both lines had typical iPSC morphology, expressed canonical pluripotency markers, exhibited trilineage differentiation potential, and had normal karyotypes. Together with existing RYR1 iPSC lines, these represent important tools to study and develop treatments for RYR1-related myopathies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ryanodine Receptor Calcium Release Channel / Mutation, Missense / Induced Pluripotent Stem Cells Limits: Adult / Female / Humans / Male Language: En Journal: Stem Cell Res Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ryanodine Receptor Calcium Release Channel / Mutation, Missense / Induced Pluripotent Stem Cells Limits: Adult / Female / Humans / Male Language: En Journal: Stem Cell Res Year: 2024 Document type: Article